Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 3618 entries
Sorted by: Best Match Show Resources per page
In Vitro activity of daptomycin against MRSA and vancomycin hetero-resistant MRSA (h-MRSA) isolated from patients at Siraj hospital

community settings

[No authors listed]
GSID: y4A06q7qmoEJ
S Trakulsomboom, V Thamlikitkul - J. Infect. Dis. Antimicrob. Agents, 2008

No abstract available.

Cite
Trakulsomboom, S., & Thamlikitkul, V. (2008). In Vitro activity of daptomycin against MRSA and vancomycin hetero-resistant MRSA (h-MRSA) isolated from patients at Siraj hospital. J. Infect. Dis. Antimicrob. Agents, 25(1), 57-61.
Trakulsomboom, S., and V. Thamlikitkul. "In Vitro activity of daptomycin against MRSA and vancomycin hetero-resistant MRSA (h-MRSA) isolated from patients at Siraj hospital." J. Infect. Dis. Antimicrob. Agents 25.1 (2008): 57-61.
Copy Download .nbib Format: MLA
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.

Antimicrobial resistance and infection control

Storm JC, Diekema DJ, Kroeger JS, Johnson SJ, Johannsson B.
PMID: 22958379
Antimicrob Resist Infect Control. 2012 May 29;1(1):19. doi: 10.1186/2047-2994-1-19.

BACKGROUND: Daptomycin non-susceptible enterococci (DNSE) are emerging as an important cause of healthcare-associated infection, however little is known about the epidemiology of DNSE. At the University of Iowa Hospitals and Clinics (UIHC) an increase in the frequency of patients...

Cite
Storm JC, Diekema DJ, Kroeger JS, et al. Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus. Antimicrob Resist Infect Control. 2012;1(1):19doi: 10.1186/2047-2994-1-19.
Storm, J. C., Diekema, D. J., Kroeger, J. S., Johnson, S. J., & Johannsson, B. (2012). Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus. Antimicrobial resistance and infection control, 1(1), 19. https://doi.org/10.1186/2047-2994-1-19
Storm, Jeremy C, et al. "Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus." Antimicrobial resistance and infection control vol. 1,1 (2012): 19. doi: https://doi.org/10.1186/2047-2994-1-19
Storm JC, Diekema DJ, Kroeger JS, Johnson SJ, Johannsson B. Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus. Antimicrob Resist Infect Control. 2012 May 29;1(1):19. doi: 10.1186/2047-2994-1-19. PMID: 22958379; PMCID: PMC3436660.
Copy Download .nbib Format: NLM
Current microbiology of surgical site infections associated with breast cancer surgery .

Wounds : a compendium of clinical research and practice

Rolston K, Mihu C, Tarrand J.
PMID: 25902178
Wounds. 2010 May;22(5):132-5.

 Surgical site infections (SSI) are the most common complications of breast cancer surgery. The authors identified 35 cases of SSI in the M.D. Anderson Cancer Center (Houston, TX) over a 7-month study period. Monomicrobial infections predominated (69%) with...

Cite
Rolston K, Mihu C, Tarrand J. Current microbiology of surgical site infections associated with breast cancer surgery . Wounds. 2010;22(5):132-5
Rolston, K., Mihu, C., & Tarrand, J. (2010). Current microbiology of surgical site infections associated with breast cancer surgery . Wounds : a compendium of clinical research and practice, 22(5), 132-5.
Rolston, Kenneth, et al. "Current microbiology of surgical site infections associated with breast cancer surgery ." Wounds : a compendium of clinical research and practice vol. 22,5 (2010): 132-5.
Rolston K, Mihu C, Tarrand J. Current microbiology of surgical site infections associated with breast cancer surgery . Wounds. 2010 May;22(5):132-5. PMID: 25902178.
Copy Download .nbib Format: NLM
Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea.

Infection & chemotherapy

Kim J, Seo MR, Kang JO, Choi TY, Pai H.
PMID: 24265965
Infect Chemother. 2013 Jun;45(2):175-83. doi: 10.3947/ic.2013.45.2.175. Epub 2013 Jun 26.

BACKGROUND: Binary toxin-producing Clostridium difficile infections (CDI) are known to be more severe and to cause higher case fatality rates than those by binary toxin-negative isolates. There has been few data of binary toxin-producing CDI in Korea. Objective of...

Cite
Kim J, Seo MR, Kang JO, et al. Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea. Infect Chemother. 2013;45(2):175-83doi: 10.3947/ic.2013.45.2.175.
Kim, J., Seo, M. R., Kang, J. O., Choi, T. Y., & Pai, H. (2013). Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea. Infection & chemotherapy, 45(2), 175-83. https://doi.org/10.3947/ic.2013.45.2.175
Kim, Jieun, et al. "Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea." Infection & chemotherapy vol. 45,2 (2013): 175-83. doi: https://doi.org/10.3947/ic.2013.45.2.175
Kim J, Seo MR, Kang JO, Choi TY, Pai H. Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea. Infect Chemother. 2013 Jun;45(2):175-83. doi: 10.3947/ic.2013.45.2.175. Epub 2013 Jun 26. PMID: 24265965; PMCID: PMC3780953.
Copy Download .nbib Format: NLM
Moxifloxacin-Induced Immune-Mediated Thrombocytopenia in a Chronic Kidney Disease Patient Receiving Hemodialysis.

The Annals of pharmacotherapy

Mailman JF, Stigant C, Martinusen D.
PMID: 24687544
Ann Pharmacother. 2014 Jul;48(7):919-922. doi: 10.1177/1060028014529929. Epub 2014 Mar 31.

OBJECTIVE: To alert clinicians to a serious complication from a commonly prescribed medication, moxifloxacin.CASE SUMMARY: A 65-year-old male, septic, hemodialysis patient developed thrombocytopenia following exposure to vancomycin, ceftazidime, and moxifloxacin. Drug-specific immunoglobulin testing showed positive autoantibodies against only moxifloxacin,...

Cite
Mailman JF, Stigant C, Martinusen D. Moxifloxacin-Induced Immune-Mediated Thrombocytopenia in a Chronic Kidney Disease Patient Receiving Hemodialysis. Ann Pharmacother. 2014;48(7):919-922doi: 10.1177/1060028014529929.
Mailman, J. F., Stigant, C., & Martinusen, D. (2014). Moxifloxacin-Induced Immune-Mediated Thrombocytopenia in a Chronic Kidney Disease Patient Receiving Hemodialysis. The Annals of pharmacotherapy, 48(7), 919-922. https://doi.org/10.1177/1060028014529929
Mailman, Jonathan F, et al. "Moxifloxacin-Induced Immune-Mediated Thrombocytopenia in a Chronic Kidney Disease Patient Receiving Hemodialysis." The Annals of pharmacotherapy vol. 48,7 (2014): 919-922. doi: https://doi.org/10.1177/1060028014529929
Mailman JF, Stigant C, Martinusen D. Moxifloxacin-Induced Immune-Mediated Thrombocytopenia in a Chronic Kidney Disease Patient Receiving Hemodialysis. Ann Pharmacother. 2014 Jul;48(7):919-922. doi: 10.1177/1060028014529929. Epub 2014 Mar 31. PMID: 24687544.
Copy Download .nbib Format: NLM
The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary study.

Infection & chemotherapy

Hwang JH, Lee JH, Moon MK, Kim JS, Won KS, Lee CS.
PMID: 24265951
Infect Chemother. 2013 Mar;45(1):62-8. doi: 10.3947/ic.2013.45.1.62. Epub 2013 Mar 29.

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) has become a one of the most important causes of nosocomial infections, and use of vancomycin for the treatment of MRSA infection has increased. Unfortunately, vancomycin-resistant enterococcus have been reported, as well as vancomycin-resistant...

Cite
Hwang JH, Lee JH, Moon MK, et al. The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary study. Infect Chemother. 2013;45(1):62-8doi: 10.3947/ic.2013.45.1.62.
Hwang, J. H., Lee, J. H., Moon, M. K., Kim, J. S., Won, K. S., & Lee, C. S. (2013). The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary study. Infection & chemotherapy, 45(1), 62-8. https://doi.org/10.3947/ic.2013.45.1.62
Hwang, Ji-Hee, et al. "The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary study." Infection & chemotherapy vol. 45,1 (2013): 62-8. doi: https://doi.org/10.3947/ic.2013.45.1.62
Hwang JH, Lee JH, Moon MK, Kim JS, Won KS, Lee CS. The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary study. Infect Chemother. 2013 Mar;45(1):62-8. doi: 10.3947/ic.2013.45.1.62. Epub 2013 Mar 29. PMID: 24265951; PMCID: PMC3780940.
Copy Download .nbib Format: NLM
Fulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin.

Case reports in medicine

Cheung SW, Li KK.
PMID: 27034681
Case Rep Med. 2016;2016:4609824. doi: 10.1155/2016/4609824. Epub 2016 Feb 29.

Clostridium difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea. Severe diseases carry significant morbidities such as septic shock, acute kidney injury, bowel perforation, and mortality. Immunocompromising conditions increase the risk of developing the disease but whether...

Cite
Cheung SW, Li KK. Fulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin. Case Rep Med. 2016;2016:4609824doi: 10.1155/2016/4609824.
Cheung, S. W., & Li, K. K. (2016). Fulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin. Case reports in medicine, 20164609824. https://doi.org/10.1155/2016/4609824
Cheung, Sai Wah, and Li, Kin Kong. "Fulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin." Case reports in medicine vol. 2016 (2016): 4609824. doi: https://doi.org/10.1155/2016/4609824
Cheung SW, Li KK. Fulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin. Case Rep Med. 2016;2016:4609824. doi: 10.1155/2016/4609824. Epub 2016 Feb 29. PMID: 27034681; PMCID: PMC4789425.
Copy Download .nbib Format: NLM
Impact of Pharmacy Practice Model Expansion on Pharmacokinetic Services: Optimization of Vancomycin Dosing and Improved Patient Safety.

Hospital pharmacy

Han Z, Pettit NN, Landon EM, Brielmaier BD.
PMID: 28515506
Hosp Pharm. 2017 Apr;52(4):273-279. doi: 10.1310/hpj5204-273.

No abstract available.

Cite
Han Z, Pettit NN, Landon EM, et al. Impact of Pharmacy Practice Model Expansion on Pharmacokinetic Services: Optimization of Vancomycin Dosing and Improved Patient Safety. Hosp Pharm. 2017;52(4):273-279doi: 10.1310/hpj5204-273.
Han, Z., Pettit, N. N., Landon, E. M., & Brielmaier, B. D. (2017). Impact of Pharmacy Practice Model Expansion on Pharmacokinetic Services: Optimization of Vancomycin Dosing and Improved Patient Safety. Hospital pharmacy, 52(4), 273-279. https://doi.org/10.1310/hpj5204-273
Han, Zhe, et al. "Impact of Pharmacy Practice Model Expansion on Pharmacokinetic Services: Optimization of Vancomycin Dosing and Improved Patient Safety." Hospital pharmacy vol. 52,4 (2017): 273-279. doi: https://doi.org/10.1310/hpj5204-273
Han Z, Pettit NN, Landon EM, Brielmaier BD. Impact of Pharmacy Practice Model Expansion on Pharmacokinetic Services: Optimization of Vancomycin Dosing and Improved Patient Safety. Hosp Pharm. 2017 Apr;52(4):273-279. doi: 10.1310/hpj5204-273. PMID: 28515506; PMCID: PMC5424831.
Copy Download .nbib Format: NLM
[Is there a relationship between rectal colonization and nosocomial infection of patients in intensive care unit?].

Mikrobiyoloji bulteni

Yeşilbağ Z, Çağatay AA, Karadeniz A, Başaran S, Orhun G, Ergin Özcan P, Özsüt H, Eraksoy H.
PMID: 26313275
Mikrobiyol Bul. 2015 Jul;49(3):327-39. doi: 10.5578/mb.9343.

Nosocomial infections caused by multidrug-resistant (MDR) microorganisms are a major problem in intensive care units (ICUs) with high mortality and morbidity rates and the prior colonization is an important risk factor for these infections. The aim of this study...

Cite
Yeşilbağ Z, Çağatay AA, Karadeniz A, et al. Yoğun bakım birimindeki hastaların rektal kolonizasyonu ile hastane enfeksiyonu arasında bir ilişki var mı? [Is there a relationship between rectal colonization and nosocomial infection of patients in intensive care unit?]. Mikrobiyol Bul. 2015;49(3):327-39doi: 10.5578/mb.9343.
Yeşilbağ, Z., Çağatay, A. A., Karadeniz, A., Başaran, S., Orhun, G., Ergin Özcan, P., Özsüt, H., & Eraksoy, H. (2015). Yoğun bakım birimindeki hastaların rektal kolonizasyonu ile hastane enfeksiyonu arasında bir ilişki var mı? [Is there a relationship between rectal colonization and nosocomial infection of patients in intensive care unit?]. Mikrobiyoloji bulteni, 49(3), 327-39. https://doi.org/10.5578/mb.9343
Yeşilbağ, Zuhal, et al. "Yoğun bakım birimindeki hastaların rektal kolonizasyonu ile hastane enfeksiyonu arasında bir ilişki var mı?" [Is there a relationship between rectal colonization and nosocomial infection of patients in intensive care unit?]. Mikrobiyoloji bulteni vol. 49,3 (2015): 327-39. doi: https://doi.org/10.5578/mb.9343
Yeşilbağ Z, Çağatay AA, Karadeniz A, Başaran S, Orhun G, Ergin Özcan P, Özsüt H, Eraksoy H. Yoğun bakım birimindeki hastaların rektal kolonizasyonu ile hastane enfeksiyonu arasında bir ilişki var mı? [Is there a relationship between rectal colonization and nosocomial infection of patients in intensive care unit?]. Mikrobiyol Bul. 2015 Jul;49(3):327-39. doi: 10.5578/mb.9343. Turkish. PMID: 26313275.
Copy Download .nbib Format: NLM
Antimicrobial activity of Nigerian medicinal plants.

Journal of intercultural ethnopharmacology

Anyanwu MU, Okoye RC.
PMID: 28512606
J Intercult Ethnopharmacol. 2017 Feb 18;6(2):240-259. doi: 10.5455/jice.20170106073231. eCollection 2017.

Antimicrobial resistance (AMR) is currently one of the major threats facing mankind. The emergence and rapid spread of multi- and pan-drug-resistant organisms (such as vancomycin-, methicillin-, extended-spectrum β-lactam-, carbapenem- and colistin-resistant organisms) has put the world in a dilemma....

Cite
Anyanwu MU, Okoye RC. Antimicrobial activity of Nigerian medicinal plants. J Intercult Ethnopharmacol. 2017;6(2):240-259doi: 10.5455/jice.20170106073231.
Anyanwu, M. U., & Okoye, R. C. (2017). Antimicrobial activity of Nigerian medicinal plants. Journal of intercultural ethnopharmacology, 6(2), 240-259. https://doi.org/10.5455/jice.20170106073231
Anyanwu, Madubuike Umunna, and Okoye, Rosemary Chinazam. "Antimicrobial activity of Nigerian medicinal plants." Journal of intercultural ethnopharmacology vol. 6,2 (2017): 240-259. doi: https://doi.org/10.5455/jice.20170106073231
Anyanwu MU, Okoye RC. Antimicrobial activity of Nigerian medicinal plants. J Intercult Ethnopharmacol. 2017 Feb 18;6(2):240-259. doi: 10.5455/jice.20170106073231. eCollection 2017. PMID: 28512606; PMCID: PMC5429085.
Copy Download .nbib Format: NLM
Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis.

Therapeutics and clinical risk management

Liu C, Mao Z, Yang M, Kang H, Liu H, Pan L, Hu J, Luo J, Zhou F.
PMID: 27703367
Ther Clin Risk Manag. 2016 Sep 22;12:1455-1466. doi: 10.2147/TCRM.S115175. eCollection 2016.

BACKGROUND: Skin and soft tissue infections (SSTIs) are significant indications for antibiotic treatment. Daptomycin, a novel antibiotic, has been registered and licensed to be used in the treatment of these infections. However, its efficacy and safety remain controversial.OBJECTIVE: The...

Cite
Liu C, Mao Z, Yang M, et al. Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis. Ther Clin Risk Manag. 2016;12:1455-1466doi: 10.2147/TCRM.S115175.
Liu, C., Mao, Z., Yang, M., Kang, H., Liu, H., Pan, L., Hu, J., Luo, J., & Zhou, F. (2016). Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis. Therapeutics and clinical risk management, 121455-1466. https://doi.org/10.2147/TCRM.S115175
Liu, Chao, et al. "Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis." Therapeutics and clinical risk management vol. 12 (2016): 1455-1466. doi: https://doi.org/10.2147/TCRM.S115175
Liu C, Mao Z, Yang M, Kang H, Liu H, Pan L, Hu J, Luo J, Zhou F. Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis. Ther Clin Risk Manag. 2016 Sep 22;12:1455-1466. doi: 10.2147/TCRM.S115175. eCollection 2016. PMID: 27703367; PMCID: PMC5038576.
Copy Download .nbib Format: NLM
Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments.

GMS hygiene and infection control

Ulrich N, Gastmeier P.
PMID: 28890862
GMS Hyg Infect Control. 2017 Aug 28;12:Doc14. doi: 10.3205/dgkh000299. eCollection 2017.

Some infection control recommendations distinguish epidemic and endemic levels for infection control. However, it is often difficult to separate long lasting outbreaks from high endemic levels and it remains open, if this distinction is really useful.

Cite
Ulrich N, Gastmeier P. Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments. GMS Hyg Infect Control. 2017;12:Doc14doi: 10.3205/dgkh000299.
Ulrich, N., & Gastmeier, P. (2017). Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments. GMS hygiene and infection control, 12Doc14. https://doi.org/10.3205/dgkh000299
Ulrich, Nikos, and Gastmeier, Petra. "Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments." GMS hygiene and infection control vol. 12 (2017): Doc14. doi: https://doi.org/10.3205/dgkh000299
Ulrich N, Gastmeier P. Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments. GMS Hyg Infect Control. 2017 Aug 28;12:Doc14. doi: 10.3205/dgkh000299. eCollection 2017. PMID: 28890862; PMCID: PMC5574254.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 3618 entries